What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer. Read more about What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer.
A sensible approach to targeting STAT3-mediated transcription. Read more about A sensible approach to targeting STAT3-mediated transcription.
Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation? Read more about Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?
Circulating CD40 autoantibody and suPAR synergy drives glomerular injury. Read more about Circulating CD40 autoantibody and suPAR synergy drives glomerular injury.
